Novavax (NVAX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

NVAX is expected to report earnings to fall 194.86% to 99 cents per share on August 06

Q2'24

Est.

$1.00

Q1'24

Missed

by $0.13

Q4'23

Missed

by $0.99

Q3'23

Beat

by $0.96

Q2'23

Beat

by $2.10

The last earnings report on May 10 showed earnings per share of -104 cents, missing the estimate of -92 cents. With 4.48M shares outstanding, the current market capitalization sits at 2.46B.

View a ticker or compare two or three

Compare

NVAX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NVAX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for NVAX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a company which engages in development of novel recombinant vaccines

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

700 Quince Orchard Road

Phone

+1 240 268-2000

Employees

1534

Web

https://www.novavax.com